Advanced Search

ICD-10-PCS code List for Glucarpidase

ICD-10-PCS code List for Glucarpidase is medical classification list by Centers for Medicare and Medicaid Services (CMS).

PCS Tables

PCS CODE

Description

Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Open Approach

Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach

Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach

Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach

Introduction of Anti-inflammatory into Cranial Cavity and Brain, Open Approach

Introduction of Nutritional Substance into Cranial Cavity and Brain, Open Approach

Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Open Approach

Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Open Approach

Introduction of Anesthetic Agent into Cranial Cavity and Brain, Open Approach

Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach

Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach

Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Open Approach

Introduction of Radioactive Substance into Cranial Cavity and Brain, Open Approach

Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Open Approach

Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Open Approach

Introduction of Other Gas into Cranial Cavity and Brain, Open Approach

Introduction of Destructive Agent into Cranial Cavity and Brain, Open Approach

Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Other Anti-infective into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Anti-inflammatory into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Nutritional Substance into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Anesthetic Agent into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Radioactive Substance into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Other Gas into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Destructive Agent into Cranial Cavity and Brain, Percutaneous Approach

Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Via Natural or Artificial Opening

Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening

Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening

Introduction of Other Gas into Cranial Cavity and Brain, Via Natural or Artificial Opening